Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study-Reference-Cited by-同舟云学术

Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study

Published:2021-01-22 Issue: Volume: Page:
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Yan Wei^ORCID,Wu Bin^ORCID,Liao Ai-Jun^ORCID,Yang Wei^ORCID,Wang Hui-Han^ORCID

Funder

Natural Science Foundation of Liaoning Province

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-021-04396-0.pdf

Reference24 articles.

1. Kobayashi Y (2019) JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-2. Marginal zone lymphoma (MALT lymphoma/extranidal marginal zone lymphoma of mucosa-associated lymphoid tissue and splenic marginal zone lymphoma). Int J Hematol 110:393–405. https://doi.org/10.1007/s12185-019-02719-6

2. Couto C, Martins V, Ribeiro V, Rodrigues C, Nogueira J, Oliveira A, Vieira JR (2019) Primary pulmonary MALT lymphoma: a case report and literature review. Biomed Hub 4:1–5. https://doi.org/10.1159/000502488

3. Borie R, Wislez M, Antoine M et al (2016) Pulmonary mucosa-associated lymphoid tissue lymphoma revisited. Eur Respir J 48:1252–1255. https://doi.org/10.1159/000502488

4. Sammassimo S, Pruneri G, Andreola G, Montoro J, Steffanoni S, Nowakowski GS, Gandini S, Negri M, Habermann TM, Raderer M, Li ZM, Zinzani PL, Adam P, Zucca E, Martinelli G (2016) A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of international extranodal lymphoma study group (IELSG). Hematol Oncol 34:177–183. https://doi.org/10.1002/hon.2243

5. Oh SY, Kim WS, Kim JS, Kim SJ, Kwon HC, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Lee GW, Choi CW, Park J, Suh C, Kim HJ (2010) Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: consortium for improving survival of lymphoma (CISL) study. Ann Hematol 89:563–568. https://doi.org/10.1007/s00277-009-0875-7

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary mucosa-associated lymphoid tissue lymphoma with Sjögren’s syndrome and literature review: A case report;Medicine;2023-09-15

2. Evaluation of CT features for differentiating consolidation pattern of pulmonary MALT lymphoma from pneumonic-type lung adenocarcinoma;Frontiers in Oncology;2023-09-01

3. A RARE AND INCIDENTAL FINDING OF PULMONARY MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA;Chest;2022-10

4. Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma;Frontiers in Oncology;2022-08-23

5. Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives;Cancers;2022-06-19